Clinical and economic impact of the pharmacy resident incorporation into the healthcare team;Impacto clínico y económico de la incorporación del farmacéutico residente en el equipo asistencial

Farmacia Hospitalaria

Volumn 30, Issue 5, 2006, Pages 284-290

  Arroyo Conde, Cecilia ^a,b   Aquerreta, I ^a   Ortega Eslava, A ^a   Goni Zamarbide O ^a   Giraldez Deiro J ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b NONE   (Spain)

Author keywords

Drug related problems; Healthcare team integration; Pharmaceutical care; Pharmaceutical intervention

Indexed keywords

ARTICLE; CONTROLLED STUDY; COST; DRUG ADMINISTRATION; ECONOMIC ASPECT; HEALTH CARE PERSONNEL; HOSPITAL PHARMACY; HUMAN; INTERVENTION STUDY; MEDICATION ERROR; PHARMACEUTICAL CARE; PHARMACIST; RESIDENCY EDUCATION; TREATMENT DURATION; WORK SCHEDULE;

EID: 33846200290     PISSN: 11306343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1130-6343(06)73992-7     Document Type: Article

References (30)

1. Boyko WL Jr., Yurkowski PJ, Ivey MF, Armitstead JA, Roberts BL. Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital. Am J Health Syst Pharm 1997; 54: 1591-5.
2. Wang Chin JM, Muller RJ, Lucarelli CD. A pharmacy intervention program: recognizing pharmacy's contribution to improving patient care. Hosp Pharm 1995; 30: 120-30.
3. Leape LL, Cullen DJ, Dempsey Clapp M, Burdick E, Demonaco HJ. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999; 282: 267-70.
4. Scarsi KK, Fotis MA, Noskin GA. Pharmacist participation in medical rounds reduces medication errors. Am J Health Syst Pharm 2002; 59: 2089-92.
5. Climente Martí M, Jiménez Torres NV. Impacto clínico y farmacoeconómico de las actuaciones farmacéuticas en pacientes hospitalizados. Aten Farm 2002; 4: 222-36.
6. Izco García N, Codina Jané C, Tuset Creus M, Manasanch Dalmau L, Gotsens Vila R, Ribas Sala J. Evaluación de la integración del farmacéutico en equipos de atención de unidades de hospitalización. Farm Hosp 2002; 26: 18-27.
7. Kane SL, Weber RJ, Dasta JF. The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med 2003; 29: 691-8.
8. Mc Lennan DN, Dooley MJ, Brien JE. Beneficial clinical outcomes resulting from pharmacist interventions. J Oncol Pharm Practice 1999; 5: 184-9.
9. Morrison A, Wertheimer A. Evaluation of studies investigating the effectiveness of pharmacist's clinical services. Am J Health Syst Pharm 2001; 58: 569-77.
10. Gandhi PJ, Smith BS, Tataronis GR, Maas B. Impact of a pharmacist on drug costs in a coronary care unit. Am J Health System Pharm 2001; 58: 497-503.
11. Malone DC, Carter BL, Billups SJ. An economic analysis of randomized, controlled, multicenter study of clinical phamacyst interventions for high risk veterans: the improve study. Pharmacotherapy 2000; 20: 1149-58.
12. Schumock GT, Meek PD, Ploetz PA, Vermeulen LC. Economic evaluations of clinical pharmacy services: 1988-1995. Pharmacotherapy 1996; 16: 1188-208.
13. Ottery FD. Rethinking nutricional support of the cancer patient: the new field of nutricional oncology. Seminars in Oncology 1994; 21: 770-8.
14. Camarero E, Candamio S. Recomendaciones nutricionales en el paciente oncológico. Capítulo 11. En: León Sanz M, Celaya Pérez S, editores. Manual de recomendaciones nutricionales al alta hospitalaria. Madrid: You & Us S. A.; 2001. p. 253-64.
15. Gómez Candela C, Mateo Lobo R, de Cos Blanco AI, Iglesias Rosado C, Castillo Rabaneda R. Evaluación del estado nutricional en el paciente oncológico. Capítulo 3. En: Gómez Candela C, Sastre Gallego A, editores. Soporte nutricional en el paciente oncológico. Madrid: You & Us S. A.; 2002. p. 17-30.
16. González Fernández MA, LLorente Gutiérrez J, Ruano Encinar M, Jiménez Caballero E. Atención Farmacéutica a pacientes hospitalizados. Repercusión clínica y económica. Aten Farm 2002; 61: 384-96.
17. Kanjanarat P, Winterstein A, Johns T, Hatton R, González-Roth R, Segal R. Nature of preventable adverse drug events in hospitals: a literature review. Am J Health Syst Pharm 2003; 60: 1750-9.
18. Goñi O, Arroyo C, Lacasa C, Idoate A, Giráldez J. Intervenciones farmacéuticas en el proceso de validación de la prescripción electrónica. Farm Hosp 2002; 26 (Supl.): 33-4.
19. Folli HL, Polle RL, Benitz WE, Russo JC. Medication error prevention by clinical pharmacists in two children's hospitals. Pediatrics 1987; 79: 718-22.
20. Jiménez Torres V, Font Noguera I, Climente Martí M. Problemas farmacoterapéuticos. Guía para su prevención y resolución. Valencia: AFAHPE Hospital Universitario Dr. Peset; 2003.
21. American College of Critical Care Medicine and the Society of Critical Care Medicine. Critical care services and personnel: recommendations based on a system of categorization into two levels of care. Crit Care Med 1999; 27: 422-6.
22. Society of Critical Care Medicine and American College of Clinical Pharmacy. Position paper on critical care pharmacy services. Pharmacotherapy 2000; 20: 1400-6.
23. Rudis MI, Brandl KM. Position paper on critical care pharmacy services. Society of Critical Care Medicine and American College of Clinical Pharmacy Task Force on Critical Care Pharmacy Services. Crit Care Med 2000; 28: 3746-50.
24. a ed. Fundación Española de Farmacia Hospitalaria; 2002.
25. Brennan TA, Leape LL, Laird N. Incidence of adverse events and negligence in hospitalized patients: results from the Harvard Medical practice Study I. N Engl J Med 1991; 324: 370-6.
26. Clasen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs and attributable mortality. JAMA 1997; 277: 301-6.
27. Tissot E, Cornette C, Demoly P, Jacquet M, Barale F, Capellier G. Medication errors at the administration stage in an intensive care unit. Intensive Care Med 1999; 25: 353-9.
28. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc 2001; 41: 192-9.
29. Strand LM, Cipolle RJ, Morley PC. Documenting the clinical pharmacist's activities: back to basis. Drug Intell Clin Pharm 1988; 22: 63-7.
30. Aquerreta I, Ortega A, Aldaz A, Lacasa C, Idoate A, Giráldez J. Impacto de las intervenciones de un farmacéutico en UCI en el cuidado del paciente y en el coste de la terapia. Farm Hosp 2002; 26 (Supl.): 30.